FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2784906153> ?p ?o ?g. }

• W2784906153 endingPage "211" @default.
• W2784906153 startingPage "203" @default.
• W2784906153 abstract "Purpose of review Valproic acid (VPA) is one of the four first line antiepileptic drugs (AEDs). VPA is also an effective drug in migraine prophylaxis and in treatment of bipolar disorders. The use of VPA is limited by its two rare but potentially life-threatening side effects, teratogenicity and hepatotoxicity, and it is the least potent of the established AEDs. Consequently, there is an incentive to develop a second-generation VPA. A successful, second-generation VPA would need to possess the following characteristics: broad-spectrum antiepileptic activity; better potency than VPA; and lack of teratogenicity and hepatotoxicity. These characteristics would give such a drug the potential to be utilized in epilepsy and other CNS disorders. Recent findings Intensive research has been carried out in order to develop a second-generation VPA that would be more potent and safer than VPA. Amide derivatives of VPA have shown particular value as potential follow-up compounds and have better in-vivo performance than VPA. Several CNS-active valproylamides are more potent as antiepileptics than VPA, they possess broad-spectrum antiepileptic activity, and have been found to be nonteratogenic in animal models. The amide analogues of VPA that emerged from structure-pharmacokinetic-pharmacodynamic relationship studies as promising second-generation compounds are: N-methyl-tetramethylcyclopropane carboxamide, (2S,3S)-valnoctamide, (R)-propylisopropyl acetamide and valproyl glycinamide. Summary At present there are three compounds in clinical trials in patients with epilepsy that can be regarded as second-generation VPA: valproyl glycinamide, 3-methylbutanamide or isovaleramide and SPD421 (DP-VPA). For any one of these second-generation valproic acids to become a successful follow-up compound to VPA, it has to fulfil the above criteria and also possess favorable pharmacokinetics." @default.
• W2784906153 created "2018-02-02" @default.
• W2784906153 creator A5001346835 @default.
• W2784906153 creator A5036636635 @default.
• W2784906153 creator A5089448145 @default.
• W2784906153 date "2003-04-01" @default.
• W2784906153 modified "2023-10-12" @default.
• W2784906153 title "New CNS-active drugs which are second-generation valproic acid: can they lead to the development of a magic bullet?" @default.
• W2784906153 cites W103743773 @default.
• W2784906153 cites W125678881 @default.
• W2784906153 cites W125743501 @default.
• W2784906153 cites W1598267163 @default.
• W2784906153 cites W166461904 @default.
• W2784906153 cites W182140896 @default.
• W2784906153 cites W191660492 @default.
• W2784906153 cites W1964650076 @default.
• W2784906153 cites W1968305447 @default.
• W2784906153 cites W1970354875 @default.
• W2784906153 cites W1973350716 @default.
• W2784906153 cites W1979233147 @default.
• W2784906153 cites W1984521290 @default.
• W2784906153 cites W1986204130 @default.
• W2784906153 cites W1988321504 @default.
• W2784906153 cites W1991269972 @default.
• W2784906153 cites W1994524362 @default.
• W2784906153 cites W1996318087 @default.
• W2784906153 cites W2001404673 @default.
• W2784906153 cites W2002232198 @default.
• W2784906153 cites W2007434627 @default.
• W2784906153 cites W2008494261 @default.
• W2784906153 cites W2010364904 @default.
• W2784906153 cites W2016323460 @default.
• W2784906153 cites W2016777209 @default.
• W2784906153 cites W2018759446 @default.
• W2784906153 cites W2020156219 @default.
• W2784906153 cites W2026391956 @default.
• W2784906153 cites W2044488698 @default.
• W2784906153 cites W2044984495 @default.
• W2784906153 cites W2047732548 @default.
• W2784906153 cites W2048234795 @default.
• W2784906153 cites W2050524083 @default.
• W2784906153 cites W2053923389 @default.
• W2784906153 cites W2062020340 @default.
• W2784906153 cites W2065461165 @default.
• W2784906153 cites W2071250746 @default.
• W2784906153 cites W2080483323 @default.
• W2784906153 cites W2081266818 @default.
• W2784906153 cites W2088372657 @default.
• W2784906153 cites W2090692462 @default.
• W2784906153 cites W2103195097 @default.
• W2784906153 cites W2126768116 @default.
• W2784906153 cites W2147848178 @default.
• W2784906153 cites W2264083052 @default.
• W2784906153 cites W2314644419 @default.
• W2784906153 cites W2404144897 @default.
• W2784906153 cites W2406919090 @default.
• W2784906153 cites W2920807090 @default.
• W2784906153 cites W308130168 @default.
• W2784906153 doi "https://doi.org/10.1097/00019052-200304000-00014" @default.
• W2784906153 hasPublicationYear "2003" @default.
• W2784906153 type Work @default.
• W2784906153 sameAs 2784906153 @default.
• W2784906153 citedByCount "62" @default.
• W2784906153 countsByYear W27849061532012 @default.
• W2784906153 countsByYear W27849061532013 @default.
• W2784906153 countsByYear W27849061532015 @default.
• W2784906153 countsByYear W27849061532017 @default.
• W2784906153 countsByYear W27849061532018 @default.
• W2784906153 countsByYear W27849061532019 @default.
• W2784906153 countsByYear W27849061532020 @default.
• W2784906153 countsByYear W27849061532021 @default.
• W2784906153 countsByYear W27849061532023 @default.
• W2784906153 crossrefType "journal-article" @default.
• W2784906153 hasAuthorship W2784906153A5001346835 @default.
• W2784906153 hasAuthorship W2784906153A5036636635 @default.
• W2784906153 hasAuthorship W2784906153A5089448145 @default.
• W2784906153 hasConcept C112705442 @default.
• W2784906153 hasConcept C118552586 @default.
• W2784906153 hasConcept C178790620 @default.
• W2784906153 hasConcept C185592680 @default.
• W2784906153 hasConcept C2775858608 @default.
• W2784906153 hasConcept C2776730177 @default.
• W2784906153 hasConcept C2777172819 @default.
• W2784906153 hasConcept C2778186239 @default.
• W2784906153 hasConcept C2780035454 @default.
• W2784906153 hasConcept C2992152733 @default.
• W2784906153 hasConcept C60644358 @default.
• W2784906153 hasConcept C71924100 @default.
• W2784906153 hasConcept C86803240 @default.
• W2784906153 hasConcept C98274493 @default.
• W2784906153 hasConceptScore W2784906153C112705442 @default.
• W2784906153 hasConceptScore W2784906153C118552586 @default.
• W2784906153 hasConceptScore W2784906153C178790620 @default.
• W2784906153 hasConceptScore W2784906153C185592680 @default.
• W2784906153 hasConceptScore W2784906153C2775858608 @default.
• W2784906153 hasConceptScore W2784906153C2776730177 @default.
• W2784906153 hasConceptScore W2784906153C2777172819 @default.
• W2784906153 hasConceptScore W2784906153C2778186239 @default.

• next